MICHAEL MALLOY: Open Payments
NPI 1679597371 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,057 in 115 payments from 12 companies in 2025. Trend: 2023 $2,537 · 2024 $2,528 · 2025 $2,057
Food & beverage: $2,057
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $707 |
| Amgen Inc. | 45 | $622 |
| Novartis Pharmaceuticals Corporation | 7 | $152 |
| PFIZER INC. | 6 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $89 |
| UCB, Inc. | 3 | $83 |
| Mallinckrodt Hospital Products Inc. | 2 | $75 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Janssen Biotech, Inc. | 2 | $41 |
| ANI Pharmaceuticals, Inc. | 1 | $34 |
Products named: RINVOQ, ENBREL, SKYRIZI, COSENTYX, KRYSTEXXA, TAVNEOS, SAPHNELO, Bimzelx.
Industry payments across OK — which companies pay providers there.
